When should nitroglycerin be withheld or is contraindicated?

When Nitroglycerin Cannot Be Given

Nitroglycerin is absolutely contraindicated in patients with systolic blood pressure <90 mmHg or a drop ≥30 mmHg below baseline, recent phosphodiesterase-5 inhibitor use (within 24 hours for sildenafil/vardenafil or 48 hours for tadalafil), right ventricular infarction, increased intracranial pressure, and concurrent use of soluble guanylate cyclase stimulators like riociguat. 1, 2, 3

Absolute Contraindications

Hypotension

• Systolic blood pressure <90 mmHg is an absolute contraindication to nitroglycerin administration 1, 3
• A drop in systolic blood pressure ≥30 mmHg below baseline also contraindicates use 1, 4
• Even a single sublingual dose may be attempted in hospital settings with IV access if ischemic pain is ongoing, but only with extreme caution and continuous monitoring 1

Phosphodiesterase-5 Inhibitor Use

• Within 24 hours of sildenafil or vardenafil use, nitroglycerin is absolutely contraindicated 1, 2, 5, 3
• Within 48 hours of tadalafil use, nitroglycerin is absolutely contraindicated 1, 2, 5, 3
• The combination causes profound, life-threatening hypotension through potentiation of cGMP-mediated vasodilation 2, 5, 3
• Within 12 hours of avanafil use, nitroglycerin should be avoided 1

Right Ventricular Infarction

• Suspected or confirmed right ventricular myocardial infarction is an absolute contraindication 1, 2, 4
• These patients are critically dependent on adequate right ventricular preload to maintain cardiac output 1
• Nitroglycerin-induced preload reduction can precipitate profound hypotension and cardiovascular collapse 1

Increased Intracranial Pressure

• Any condition causing increased intracranial pressure (including intracranial hemorrhage) absolutely contraindicates nitroglycerin 2, 3
• Nitroglycerin causes cerebral vasodilation, increasing cerebral blood volume and further elevating intracranial pressure 2
• The combination of increased ICP and nitroglycerin-induced hypotension dangerously reduces cerebral perfusion pressure 2

Drug Interactions

• Concurrent use of riociguat (soluble guanylate cyclase stimulator) is contraindicated due to severe hypotension risk 3
• Known hypersensitivity or allergy to nitroglycerin or organic nitrates 3

Relative Contraindications and Extreme Caution Situations

Bradycardia and Tachycardia

• Severe bradycardia (heart rate <50 bpm) requires extreme caution or avoidance 1, 4
• Uncontrolled tachycardia (heart rate >100-110 bpm) in the absence of heart failure warrants caution 1, 4
• Nitroglycerin should be avoided when marked bradycardia or tachycardia coexists with relative hypotension 1

Specific Clinical Scenarios

• Hypertrophic cardiomyopathy: Nitrate therapy may aggravate angina in these patients 3
• Severe anemia: Listed as a contraindication in early myocardial infarction settings 3
• Volume depletion: Use with extreme caution as hypotension risk is markedly increased 3

Critical Monitoring Requirements

Before Administration

• Always verify systolic blood pressure ≥90 mmHg before each sublingual dose 1, 4
• Explicitly ask about PDE-5 inhibitor use within the past 48 hours in all patients presenting with chest pain 2, 5
• Assess for signs of right ventricular infarction (inferior wall MI with hypotension, clear lungs, elevated JVP) 1

During Administration

• Continuous blood pressure and heart rate monitoring is mandatory, especially with IV infusion 1, 4
• Avoid reducing mean arterial pressure by >15% in the first hour of therapy 4
• If profound hypotension occurs, immediately discontinue nitroglycerin, elevate legs, administer rapid IV fluids, and consider atropine for bradycardia 1

Common Pitfalls to Avoid

• Never assume topical or transdermal nitrates are safer than other formulations—all carry identical contraindications 2, 5
• Do not rely on patient recall alone for PDE-5 inhibitor use; specifically ask about sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra) 1, 2
• Inferior wall MI patients require special vigilance for right ventricular involvement before nitroglycerin administration 1
• Paradoxical bradycardia and worsening angina can occur with nitroglycerin-induced hypotension 3

Alternative Therapies When Nitroglycerin Is Contraindicated

• Beta-blockers (labetalol preferred) serve as first-line anti-ischemic therapy when nitrates cannot be used 2, 5
• Calcium channel blockers (non-dihydropyridine preferred) for recurrent ischemia 5
• Morphine or fentanyl (2-4 mg or 25-50 mcg IV) for pain relief resistant to other measures, though these may delay oral P2Y12 inhibitor absorption 1
• Nicardipine infusion (5-15 mg/h) for blood pressure control without increasing intracranial pressure 2